Log in to save to my catalogue

Assessing tafenoquine implementation in Brazil: a qualitative evaluation of perceptions of healthcar...

Assessing tafenoquine implementation in Brazil: a qualitative evaluation of perceptions of healthcar...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_878687f14d744141a998d0c922b07820

Assessing tafenoquine implementation in Brazil: a qualitative evaluation of perceptions of healthcare providers and Plasmodium vivax patients (QualiTRuST Study)

About this item

Full title

Assessing tafenoquine implementation in Brazil: a qualitative evaluation of perceptions of healthcare providers and Plasmodium vivax patients (QualiTRuST Study)

Publisher

England: BioMed Central Ltd

Journal title

Malaria journal, 2024-12, Vol.23 (1), p.399-17, Article 399

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

To eliminate malaria by 2035, Brazil must address Plasmodium vivax. Previously, first-line treatment was chloroquine plus 7-day primaquine (PQ) without glucose-6-phosphate dehydrogenase (G6PD) deficiency testing. In 2021, point-of-care quantitative G6PD testing and single-dose tafenoquine (TQ) were piloted in two municipalities. This study evaluate...

Alternative Titles

Full title

Assessing tafenoquine implementation in Brazil: a qualitative evaluation of perceptions of healthcare providers and Plasmodium vivax patients (QualiTRuST Study)

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_878687f14d744141a998d0c922b07820

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_878687f14d744141a998d0c922b07820

Other Identifiers

ISSN

1475-2875

E-ISSN

1475-2875

DOI

10.1186/s12936-024-05209-1

How to access this item